Literature DB >> 24861033

Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.

Zheng Chen1, Cheng-Kun Han, Ling-Ling Pan, Hui-Jie Zhang, Zhi-Min Ma, Zhu-Feng Huang, Shi Chen, Xiong-Jie Zhuang, Zhi-Bin Li, Xiao-Ying Li, Xue-Jun Li, Shu-Yu Yang.   

Abstract

BACKGROUND AND AIM: Liver enzymes including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-glutamyltransferase (GGT) are well recognized as surrogate makers reflecting non-alcoholic fatty liver disease (NAFLD). However, the associations of serum ALT, AST and GGT with hepatic lipid contents are not well established. The aim of this study was to investigate the relationship between liver enzymes and intrahepatic triglyceride (IHTG) contents, and explore the feasibility in using liver enzymes to reflect accumulation of IHTG in obese subjects.
METHODS: A cross-sectional analysis was conducted in 475 obese adults aged 40-65 years. Anthropometric parameters and blood biochemical indexes including liver enzymes, glucose and lipid profiles were measured. The liver triglyceride contents of subjects were determined by (1)H-MRS.
RESULTS: Serum ALT, AST and GGT were positively correlated with IHTG contents (p < 0.01). Serum ALT, AST and GGT levels at the highest quartile of IHTG contents were significantly elevated as compared with those in the lowest quartile (p < 0.01). Multivariate linear regression analysis demonstrated that serum ALT, but not AST or GGT was independently associated with IHTG contents. By logistic regression analysis, the odds ratio for higher IHTG contents was increased by 1.464 times/1 SD increase in serum ALT level after adjusting for multiple confounding factors [OR (95% CI) 2.464 (1.584-3.834)]. However, these relationships could not be observed between serum AST or GGT with IHTG contents.
CONCLUSIONS: Serum ALT level is independently correlated with the hepatic triglyceride contents in obese subjects and more appropriate to be used as a predictor for the degree of NAFLD rather than AST and GGT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24861033     DOI: 10.1007/s10620-014-3214-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

2.  Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population.

Authors:  Naoki Tanaka; Eiji Tanaka; Yo Sheena; Michiharu Komatsu; Wataru Okiyama; Noriko Misawa; Hidetomo Muto; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Akira Horiuchi; Kendo Kiyosawa
Journal:  Liver Int       Date:  2006-10       Impact factor: 5.828

3.  Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.

Authors:  Sung Keun Park; Mi Hae Seo; Ho Cheol Shin; Jae-Hong Ryoo
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Biliary excretion of gamma-glutamyltransferase. Selective enhancement by acute ethanol administration.

Authors:  R Teschke; T Koch
Journal:  Biochem Pharmacol       Date:  1986-08-01       Impact factor: 5.858

6.  Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

Authors:  P André; B Balkau; C Born; M A Charles; E Eschwège
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

7.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

9.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.

Authors:  Hyeon Chang Kim; Chung Mo Nam; Sun Ha Jee; Kwang Hyub Han; Dae Kyu Oh; Il Suh
Journal:  BMJ       Date:  2004-03-17

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  8 in total

1.  Effects of repeated high dosage of chloral hydrate and pentobarbital sodium anesthesia on hepatocellular system in rats.

Authors:  Jianhong Yu; Xuehui Sun; Guifeng Sang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.

Authors:  Violeta B Popov; Christopher C Thompson; Nitin Kumar; Maria M Ciarleglio; Yanhong Deng; Loren Laine
Journal:  Dig Dis Sci       Date:  2016-05-20       Impact factor: 3.199

Review 3.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

4.  Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults.

Authors:  Huijie Zhang; Zhimin Ma; Lingling Pan; Yanfang Xu; Jin Shao; Zhufeng Huang; Zheng Chen; Qian Sun; Changqin Liu; Mingzhu Lin; Shuyu Yang; Xuejun Li
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

5.  Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma.

Authors:  Hong-Yue Ren; Fan Liu; Gui-Li Huang; Yu Liu; Jin-Xing Shen; Pan Zhou; Wen-Ming Liu; Dong-Yan Shen
Journal:  Oncotarget       Date:  2017-01-24

6.  Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population.

Authors:  Dariusz Narankiewicz; Josefina Ruiz-Nava; Veronica Buonaiuto; María Isabel Ruiz-Moreno; María Dolores López-Carmona; Luis Miguel Pérez-Belmonte; Ricardo Gómez-Huelgas; María Rosa Bernal-López
Journal:  Int J Environ Res Public Health       Date:  2020-05-18       Impact factor: 3.390

7.  Association between Alanine Aminotransferase and Growth Hormone: A Retrospective Cohort Study of Short Children and Adolescents.

Authors:  Baolan Ji; Mei Zhang; Qianqian Zhao; Yuntian Chu; Yanying Li; Hui Pan; Bo Ban
Journal:  Biomed Res Int       Date:  2019-04-03       Impact factor: 3.411

8.  Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.

Authors:  Amedeo Lonardo; Dante Romagnoli
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.